Potential New Category,Occurrences
Sample ID,294610
RAW_FILE_NAME,170561
Subject ID,134190
Sex,54196
Treatment,40504
Batch,29198
Visit,24544
Group,23952
Age in Days,23120
cc,23120
Sample Type,22616
Age,18014
sex,16953
Gender,16609
Genotype,15971
Disease,15746
ia_control,14995
ia_endptage_2,14995
ia_case_ind_2,14995
Sample source,14566
age,14366
Factor,12626
Timepoint,12425
Race,10746
BMI,9696
Analysis Order,8464
Diagnosis,7824
Sample type,7443
raw_file,7241
HHEAR-ECHO ID,7174
Time,7062
treatment,6827
ia_endptage_1,6061
ia_case,6061
ia_case_ind_1,6061
FIRST_NAME,5798
LAST_NAME,5798
INSTITUTE,5798
EMAIL,5797
ADDRESS,5692
PHONE,5560
t1d_control,5537
t1d_case_ind_2,5537
t1d_endptage_2,5537
Species,5390
INSTRUMENT_NAME,5270
batch,5186
Date Analyzed,4846
Tissue,4839
Sample.Matrix,4655
Time point,4634
Type,4490
RAW_FILE_NAME(Raw file name),4326
gender,3882
Diet,3874
CHEAR_Project_ID,3809
Condition,3566
SAMPLE_TYPE,3558
group,3511
SampleType,3455
DEPARTMENT,3448
Organ,3264
Ethnicity,3255
GENDER,3233
Replicate,3197
Strain,3142
type,3076
AGE,2976
PROJECT_TITLE,2899
STUDY_TITLE,2899
STUDY_SUMMARY,2891
SUBJECT_SPECIES,2881
PROJECT_SUMMARY,2870
LABORATORY,2868
ANALYSIS_TYPE,2863
SUBJECT_TYPE,2861
sample_type,2724
MS_TYPE,2660
ION_MODE,2659
INSTRUMENT_TYPE,2655
TAXONOMY_ID,2649
CHROMATOGRAPHY_TYPE,2636
COLUMN_NAME,2618
SAMPLEPREP_SUMMARY,2614
study,2564
TREATMENT_SUMMARY,2493
Annotation,2492
COLLECTION_SUMMARY,2477
Phenotype,2470
smoking_status,2443
visit,2436
experiment,2382
Date,2357
chromatography,2282
class,2275
column,2198
Age.At.Blood.Draw,2198
rep,2163
CHEAR_Project ID,2158
FACTORS,2158
Source,2139
genotype,2135
media,2110
replicate,2093
Subject,2085
c18positive,2070
order,2040
c18negative,2024
hilicpositive,2006
Clinical group,1990
Cohort,1979
Raw files,1885
taxonomy,1862
genus,1862
phylum,1862
family,1862
MS_COMMENTS,1841
t1d_case,1835
t1d_case_ind_1,1835
t1d_endptage_1,1835
subculture_time,1786
adj_density_mesa,1773
timepoint,1723
Region,1721
Trial,1695
Smoking Status,1680
Derived_Age_at_Consent,1677
"OS (Overall Survival, months)",1677
time,1675
preculture_time,1668
Weight,1645
Celltype,1607
Category,1585
Plasma,1581
Status,1572
Site,1568
race,1552
Class,1454
GROUP,1450
AS participant,1439
raw file name,1433
Subject_ID,1421
Sample Provider,1411
Class-4,1387
Collection Time (hours),1387
sample_name,1368
host_age,1348
sample_title,1336
Smoker,1324
NDAR.GUID,1316
RUN.DAY,1298
Phase_study,1298
Biological Replicate,1282
2-Tier VIDAS/C6+,1276
2-Tier VIDAS / Marblot,1276
2- Tier C6+ / Marblot,1276
Sample Purpose,1276
CHROMATOGRAPHY_SUMMARY,1274
strain,1260
Liver.ALT,1254
Platelets.E10-9.per.L,1254
Liver.AST,1254
T2DM,1254
AST.ALT.Ratio,1254
NAFLD.Category,1246
NAS,1244
FLOW_RATE,1236
Kleiner.Steatosis,1232
Precursor,1232
TIMEPOINT,1222
CRF_MSKCC_Risk_Group,1221
Prior antiangiogenic regimens (≥2),1221
TimePoint,1219
Time Point,1201
Tissue type,1198
Height,1197
Sample Group,1174
SEX,1167
Temperature,1164
Pheotypes,1160
SOLVENT_A,1159
PROJECT_TYPE,1156
LungCancer,1152
COLUMN_TEMPERATURE,1152
SOLVENT_B,1148
Drug,1137
Inflammation,1134
Brain region,1127
ccenter,1125
race.eth,1125
FEV1_post.2,1125
age_visit,1125
STUDY_TYPE,1120
Sample,1116
Plate,1106
Experiment,1104
plasma,1074
ms,1068
Treatment (pre-post),1068
ATS_PackYears,1060
tissue,1050
IL10,1044
GMCSF,1041
VEGF,1040
IL6,1039
MCP1,1036
RANTES,1036
FLOW_GRADIENT,1020
Grouping,1018
Country,1016
HRM_Sample_Type,1011
Occupation,996
Time (mins),986
Sample description,971
Instrument Mode,964
CF,964
ID,963
Sample_type,947
Kleiner.Fibrosis,934
NUM_GROUPS,934
kingdom,931
C4-POS RAW FILE,928
Classifications,928
Cell Culture Media,928
LINE,928
HILIC-NEG RAW FILE,928
HILIC-POS RAW FILE,928
Doubling time (hr),928
TOTAL_SUBJECTS,926
Run,926
Diabetes,923
Study_Wave,919
Media,919
Ballooning,910
Stage,904
Smoking,890
sample type,888
Date of study,882
RACE,873
Raw File,863
Disease Status,852
Analysis,850
Aspirin Dosage,846
IonizationMode,846
Center,846
Education,844
Label,839
Sample contents,836
Inject. volume (µL),831
Class ID,831
Included,831
Analytical order,830
Data type,827
HHEAR ID,824
Organism,806
Cell line,805
groups,804
grouping,796
Day,793
STORAGE_CONDITIONS,782
GA,781
Gestational age Range,781
"Serum Heat inactivated (56C, 30 min)",758
Note,757
FUNDING_SOURCE,753
CASE_GROUP,751
SMOKE,751
FSMOKE,751
REGION,751
DONOR_ID,751
SMOKEYRS,751
Acquisition method,741
phenotype,740
SAMPLEPREP_PROTOCOL_FILENAME,732
TIME_TO_TB,731
Trimester,719
Severity,715
F_ID,713
Collection Time,709
MS_RESULTS_FILE,703
Microbiota,702
CO2,700
Neutrophil %,700
D-dimer,700
CRP,700
Neutrophil absolute,700
IL1Ra,700
IL1b,700
MIP1a,700
IL15,700
IL2R,700
HGF,700
IL8,700
Asymptomatic,700
Mortality Status,700
Symptom Fever,700
Hospitalized?,700
Admitted to the ICU,700
SARS-CoV-2 Positive,700
WU day of presentation,700
Symptom: Sore throat,700
Age at Symptom onset (years),700
Symptom Headache,700
Symptom Cough,700
Symptom Shortness of breath,700
MIG,698
SubjectID,692
Study,683
Variant,680
organ,676
Lymphocyte %,672
Lymphocyte absolute,672
OS_Censor (1 means the time is a censoring time and 0 means a failure time in OS),672
Fiber,670
cell_type,670
Time from symptom onset to ICU (days),668
Age Group,668
Polarity,667
Cell type,662
Nucleotide,660
Study_Diet,652
Days post symptom onset,652
AcetateGroup,649
COPD,649
BMI_CM_V1,648
POST_FEV1_DERV_V1,648
RACE.ETH,648
Conditions,648
smokStatus,648
SITE_cat,648
AGE_DERV_V1,648
Chemotherapy,647
Collection Type,647
Stuy type,643
UniqueID,642
Sequence,642
Cluster,642
Position,642
Analysis type,640
Case,637
Radiation Dose,636
Subject on ventilation at any point after d0,631
day,628
NMR_ID,623
RAW_FILE_NAME(Raw_FILE_NAME),620
Sample_id (CAS),619
Order,618
Prior Infection,617
Days since Inoculation,617
PreCultureMorphology,614
OD,614
BMIBeforeCOVID-19MedianValue,609
days_btwn_diagnosis,609
COVID-19_confirm_date,609
collection_date,609
Plasma_Age,609
hasSmokingBeforeCOVID-19,609
Severity_Scale,609
Vaccination_state,605
Antibiotics,604
Rep,602
Age(weeks),602
Model,602
Parity,600
RAW_FILE_NAME(Raw_File_Name),599
Juice type,597
SMOKING_PACK_YEARS_V1,593
Provenance,590
Neuropathy,586
Population,584
HeartFailure,580
ChronicLungDisease,580
CLIENT MATRIX,580
Stroke,580
Hypertension,580
Ulcer,580
CLIENT IDENTIFIER,580
Angina,580
HeartAttack,580
BPH,580
PARENT SAMPLE ID,580
SAMPLE AMOUNT,580
PreviousPositiveBiopsy,580
IBD,580
EthnicityLatino,580
SAMPLE NAME,580
PrDrugNone,580
Employment,580
CLIENT SAMPLE NUMBER,580
BOX NUMBER,580
Cirrhosis,580
Prostatitis,580
Depression,580
PrDrug6,580
FamilyHistoryPrCa,580
PreviousCancer,580
Arthritis,580
SampleID,580
Urethritis,580
UrinaryInfection,580
Hematuria,580
PrProcedure,580
DREresults,580
IndexOther,580
PrevBiopsy,580
FamilyHistory,580
ASAP,580
Atypia,580
HGPIN,580
AbnormBiopsy,580
PrDrug2,580
PrDrug5,580
VOLUME EXTRACTED,580
AUAscore,580
PrDrug3,580
AUAqol,580
RisingPSA,580
ElevatedPSA,580
PercFreePSA,580
SmokingEver,580
PreBioPSA,580
PrDrug1,580
AbnormDRE,580
PrDrug4,580
Asthma,579
ionmode,576
Factor1,573
Rat_number,563
Rat_sample_name,563
Cage,561
AGE_OR_AGE_RANGE,557
Age (Months),557
Mode,554
Irritable bowel syndrome,546
Myasthenia gravis,546
Guillian-Barre Syndrome,546
Erythema nodosum,546
Uveitis,546
Pericarditis,546
Myocarditis,546
Dermatitis herpetiformis,546
Multiple sclerosis,546
Pernicious anemia,546
Pemphigus vulgaris,546
Alopecia areata,546
Hashimoto's (autoimmune) thyroiditis,546
Idiopathic pulmonary fibrosis,546
Idiopathic thrombocytopenia purpura,546
Chronic bronchitis,546
Aphthous ulcers,546
Cancer - lung,546
Cancer - colon or rectum,546
Cancer - lymphoma (not otherwise specified),546
Cancer - Non-Hodkin's lymphoma,546
Cancer - ovarian,546
Cancer - liver,546
Cancer - Hodgkin's lymphoma,546
Cancer - prostate,546
Celiac sprue,546
Cancer - cholangiocarcinoma,546
Pyoderma gangrenosum,546
Cancer - breast,546
Arthralgias,546
Abscess,546
New fistula,546
Grave's disease,546
Familial Mediterranean fever,546
Anal fissure,546
Primary sclerosing cholangitis,546
Site Sub Coll,546
Polymyositis or dermatomyositis,546
Systemic lupus erythematosis,546
ThreeorMoreBursts,546
ICShighdose,546
AgeatEnrollment,546
AsthmaDurationYears,546
LABA,546
Montelukast,546
Autoimmune hemolytic anemia,546
Wegener's granulomatosis,546
Date of Receipt,546
Arthritis (uncertain diagnosis),546
Primary biliary cirrhosis,546
Visit number,546
Ankylosing spondylitis,546
Vitiligo,546
Psoriasis,546
Type I Diabetes (Juvenile Diabetes),546
Rheumatoid arthritis,546
Sarcoidosis,546
Scleroderma (systemic sclerosis),546
"Thyroid disease (uncertain diagnosis, not cancer)",546
Sjogren's syndrome,546
Partial Endoscopy,546
Temporal arteritis,546
Interval,546
Interval Name,546
Hispanic or Latino Origin,546
Site Name,546
Interval Sequence,546
Was subject terminated by investigator?,546
Did the subject withdraw from the study?,546
Immunosuppressants (e.g. oral corticosteroids),546
Did the patient sign informed consent?,546
Bechet's syndrome,546
Autoimmune hepatitis,546
"Fruit juice (orange, apple, cranberry, prune etc.)",542
Water,542
"Alcohol (beer, brandy, spirits, hard liquor, wine, aperitif, etc.)",542
Tea or coffee no sugar and no sugar replacement,542
"Red meat (beef, hamburger, pork, lamb)",541
"Diet soft drinks, tea or coffee with sugar (Stevia, Equal, Splenda etc)",540
"White meat (chicken, turkey, etc.)",540
"Processed meat (other red or white meat such as lunch meat, ham, salami, bologna",540
"Starch (white rice, bread, pizza, potatoes, yams, cereals, pancakes, etc.)",540
"Beans (tofu, soy, soy burgers, lentils, Mexican beans, lima beans etc)",540
"Whole grains (wheat, oats, brown rice, rye, quinoa, wheat bread, wheat pasta)",539
Strain2,539
"Shellfish (shrimp, lobster, scallops, etc.)",539
"Fish (fish nuggets, breaded fish, fish cakes, salmon, tuna, etc.)",539
"Fruits (no juice) (Apples, raisins, bananas, oranges, strawberries, blueberries",539
"Sweets (pies, jam, chocolate, cake, cookies, etc.)",539
Probiotic,539
"Soft drinks, tea or coffee with sugar (corn syrup, maple syrup, cane sugar, etc)",539
Sample Source,538
"Dairy (milk, cream, ice cream, cheese, cream cheese)",538
"Yogurt or other foods containing active bacterial cultures (kefir, sauerkraut)",538
"Vegetables (salad, tomatoes, onions, greens, carrots, peppers, green beans, etc)",536
Eggs,535
Education Level,533
Parent,530
"4) In the past 2 weeks, have you had diarrhea?",527
Run_order,527
"3) In the past 2 weeks, have you used an oral contrast",526
"2) In the past 2 weeks, have you undergone a colonoscopy or other procedure",526
"5) In the past 2 weeks, have you been hospitalized?",525
6) Have you ever had bowel surgery?,525
Treatment Group,521
"1) In the past 2 weeks, have you received any of the following medications",517
chormatography,516
Smoke Now?,513
Age at Consent,513
Disease type,513
12 drinks/Year?,513
Sample treatment,512
AST,511
Volume,510
OtherName,510
LABORATORY_NAME,507
Matched (Yes/No),504
bmi,501
hour,500
Hemoglobin,500
White Blood Cell Count,500
Monocytes (%),498
ALT,497
Disease_Status,496
multiomics_ID,496
CRP_Absolute,496
CRP_Category,496
FCP_Absolute,496
IIRN_Flare,496
FCP_Category,496
Dx,496
GENOTYPE_STRAIN,495
MS_mode,494
Groups,482
Week Number,477
PROCESSING_STORAGE_CONDITIONS,475
Interval days,475
Biological replicate,474
Strain type,467
Factor3,467
EXTRACT_STORAGE,466
Assay,465
Healthy,464
time point,462
protocol.id,460
Units,460
subject,459
Age  (weeks),459
Parasitemia,458
Sodium level,452
Categorization,450
Latitude,450
Longitude,450
Cox_Composite_DeathRRT,450
Cox_Mortality,450
DM_5crit,450
Competitive_RRTvsDeath,450
Cox_RRT,450
CKD_EPI,449
Sample.No.,448
SPG,448
dilution.factor,448
InjectionOrder,448
HASnum,448
Time_death,448
Laboratory_Sample_ID,448
METHODS_FILENAME,446
Age at diagnosis,445
IAMnum,444
Time_competitive_RRTvsDeath,443
Time_Cox_RRT,443
Time_composite_deathRRT,443
Datafile Name,440
liver_cancer_outcome,438
Injection,438
Tradyn,434
donor,434
LC column type,433
MS instrument,433
Dilution factor,433
Has internal standards,433
MS polarity,433
Triplicate ID,433
Sample descritpion,427
reps,425
Causative gene,424
Dataset,424
Weight [kg],422
Height [cm],422
WeekAverage_PM2.5,420
WeekAverage_OC,420
WeekAverage_EC,420
Day5_PM2.5,420
Day1_OC.1,420
Day5_EC,420
Day1_PM2.5,420
Day1_OC,420
Day1_EC,420
VT_130905_005,420
VT_130905_003,420
HTP ID,419
factor,417
lineage_3,414
lineage_2,414
Treatments,411
gestage_serum,410
time_weeks,405
intervention,405
weight,402
weight%units,402
ETHNICITY,402
Separation,402
Ionization,402
CaseStatus,400
CC_Strain,400
weight (lbs.),400
height (in.),400
BMI_DICH,400
AGE_DICH,400
MassSpecBatch,400
lineage_1,399
Symptom,399
INFECTION,398
yrdraw,397
Mother Age,397
daysafterdelivery.x,396
oxyesgeno,396
AMD stage,396
storage,396
Ratio Lymphocytes/Neutrophils (%),394
Raw data sample name,387
Sample_Data:raw_file,384
LIPIDOMICS_BATCH,383
BATCH,383
Sample_ID,382
Body mass index,381
Breed,378
time_point,377
Replicates,376
taxonomy_id,376
species_type,376
Factor4,375
Factor5,375
Treatment_group,373
Glucose Baseline,370
Barcode,370
Weight Kg,370
Height Cm,370
Race Pca,370
Insulin Baseline,370
Glucose Post Treatment,370
Mouse.Number,369
EDTA.Volume,369
Weight.Initial,369
Experimental.Cohort,369
Mouse.Source,369
SacDay,369
Blood.Volume.Net,369
Hemolysis_notes,369
Infected_yn,369
Plasma.Volume.Gross,369
Blood.Volume.Gross,369
Temperature.Initial,369
Grade of severity,368
Waist Cm,367
Plasma.Volume.Net,367
Blood.Glucose,367
Fator,367
RBC.millions.per.uL,367
RBC.Initial.millions.per.uL,367
Date.Transpond,366
Pool,364
Blood.Glucose.Initial,364
Dataset type,363
Temperature.Delta,362
lineage_4,360
Blood.Glucose.Delta,360
Specied,360
Days of adulthood,360
PUBLICATIONS,358
Date.Infection,357
Treatment times,356
Chromatography,356
RAW_FILE_NAME(Raw_file_name),356
Experimental factor,356
Gestational Age (days),356
Weight.Percent.Loss,352
Weight.Delta,352
Technical replicate,350
Date.Arrived,349
treatment_duration_(h),348
RBC.Delta,348
Obesity,347
IL27,344
GROA,344
LIF,344
LEPTIN,343
GSCF.CSF3,343
IFNG,343
IL12P70,343
MIP1B,343
IL5,343
LIX,342
Concentration,342
Acquisition setting ID number,342
IL15.IL15R,342
IL4,342
MCSF,341
IL23,341
MCP3,341
IL31,341
IFNA,340
IL17A,339
MIP2,339
Patient group,338
IL9,338
MIP1A,337
Phynotype,336
IL3,336
culture_medium,336
Date.Birth,335
IL1A,335
TGFB,335
Line,333
EOTAXIN,332
IP10,332
Gestational Age At Sampling,331
IL18,331
Gestational Age At Delivery,331
RAW_FILE_NAME(Raw File Name),330
Plasma Volume Extracted,330
IL22,329
IL13,328
Week,327
Vendor,324
Time_from_End_of_Shock_min,324
other,322
Acquisation_mode,322
Cases/Controls,322
Pig_Model,321
IL1B,320
Factor_1 (substrate),316
TNFA,316
Factor_2 (bacteria),316
Drinking,316
Diet Duration,316
Factor_2 (time),316
SPG_inSample,315
dilution_factorAcq,315
Age (year),315
Experiment number,314
SUBMIT_DATE,313
ANALYSIS_PROTOCOL_FILE,312
Tissue/Fluid,312
Acute respiratory failure,312
Run_Order,311
Pool_Info,310
sTyr groups,309
SOFTWARE_VERSION,309
Date.d0Sampling,309
Treatedrial arm,309
24h Creatinine,309
Hispanic,308
CONTRIBUTORS,305
Fraction,305
Minutes,305
DOI,305
Sample_Number,305
Agemonths,304
protein_weight%units,304
Exercise,303
EXTRACTION_METHOD,302
mortality,300
Treatment Protocol,300
Blood Draw Hour,299
Breedvalue_cat,299
hours,299
Wght_birth_cat,299
TimeDraw (Hours),299
Breedvalue_animal,299
Air conditions,298
TREATMENT,296
GROUP_DESCRIPTION,295
RAW_FILE_NAME(mzML_FILE_NAME(mzML file name)),294
CAPILLARY_VOLTAGE,294
SAMPLE_INJECTION,292
DATA_FORMAT,291
L-carnitine Dose (g),290
Collection time,289
Full name,288
Genus,288
Host,288
Target of analysis,287
Fasting Glucose,286
Exposure,285
non-IgE CMA,284
IgE CMA,284
Recovery,284
IgE other,284
Fasting prior to blood draw (hours),284
IL28,284
Colonization,282
replicate%type,281
BileAcid,278
Type of extract collected,278
Trial arm,276
Blood_type,274
protein_weight,274
Prior Malaria Infection,273
Chloroquine Resistance,273
week,273
Current Malaria Infection,273
High/Low arterial pH,270
Medium,269
TIME_POINT,268
Collection Time (minute),268
Tabagismo_corr,268
Hradvtradyn,268
APOE genotype,268
IL2,266
Schachtman.Wang_Genotype,265
sampleFW.mg,265
Panzea_genotype_hmp321,265
Buckler.Gardner_Genotype,265
Buckler.Gardner_Accession,265
Panzea_phenotype_282NAM,265
Schachtman.Wang_Accession,265
Pedigree,265
Weight(mg),264
Alcohol Consumption,264
Income Category,264
OPERATOR_NAME,264
Cell Type,264
Ever Smoked?,264
Marital Status,264
Was HBI completed?,263
DETECTOR_TYPE,261
Drug treatment,261
Sample_collection_date,259
NMR experiement,258
culture_time,258
Injury,256
CT findings,256
General wellbeing,256
Abdominal pain,256
set,256
Antibiotic,256
GOSE,256
rack_position,256
parameters,256
Solution,256
Host Plant,256
Abdominal mass,256
DIET,255
Sample_Type,254
Log2 Parasitemia,253
Developmental stage (DPI),252
Salinity,250
Advtradyn,250
STUDY_COMMENTS,250
AcetateConcentration_mM,249
Sample.Freeze.Thaw.Cycles,247
Sample.Storage.Temp,247
Sample.Preservative,247
Sample.Container.Type,247
Sample.Shipment.Condition,247
Sample.Collection.Method,247
Box.Label,247
Box.Position,247
Location,247
Infection (Factor),247
Strain (Other),247
Time (Factor),247
LAB.ID,247
Analysis.Panel,247
Sample_quantity_uom,247
Sample_quantity,247
Fasting,246
Anesthesia / Euthanasia method,245
stage,244
raw data file name,244
Nivolumab Dose (mg/kg),244
Hours,243
GLUCOSE,243
USER_GENDER,240
Parasite.Density,240
INS_WAIS_WAIST1,240
INS_WAIS_WAIST2,240
LG_GLUCOSE,240
INS_WAIS_HIP1,240
LG_CHOL_HDLC_RATIO,240
LG_LDL,240
INS_WAIS_HIP2,240
Sample material,240
SystolicBP,240
USER_AGE,240
AGE WHOLE,240
VISIT_ID,240
condition,240
USER_RACE1,240
LG_INSULIN 2,240
DiastolicBP,240
LG_TOTCHOLESTEROL,240
LG_HDL,240
LG_TRIGLYCERIDES,240
chromatograhy,240
baseline_montreal_location,239
Description,238
Depth,238
Station,238
Sample_group,237
Extract Method,236
COLLECTION_PROTOCOL_FILENAME,236
Ion Mode,236
PMI,236
ESI,236
Solution Added,235
Urease Treatment,235
method,235
carrier_conc,235
Volume Urine (µL),235
il2_conc,235
abs_surface_density,235
Technical Replicate,235
NMR_run_ID,235
wbc(cells/uL),234
Facility,234
hgb(g/dL),234
Study type,234
"sample volume, µL",234
YOB,233
Species_strain,232
MS_run,232
Broad_taxon,232
Sample_Run_Order,232
Acquisition type,232
RPN_Filename,232
Sample Matrix,232
ZHP_Filename,232
Batch_Run_Order,232
INJECTION_TEMPERATURE,231
Time point of 13C labeling (s),231
SWATH Program,231
AGE_DERV_01,230
GOLD_STAGE_COPD_SEVERITY,230
PCT_POST_FEV1_V1,230
CBC14_DERV,230
CBC05_DERV,230
POST_FEV1FVC_DERV,230
SITE,230
BMI_CM01,230
CBC04_DERV,230
CBC_LYMPHOCYTE_CNT01,230
CBC_MONOCYTE_CNT01,230
MENOPAUSE01,230
CBC_NEUTROPHIL_CNT01,230
diet,229
ANALYTICAL_TIME,229
Pool Group,229
Osmolarity,229
NMR DRCC ID,229
Fasting Insulin (mU/mL),228
Other,228
Placenta_Surface,226
Placenta_Area,226
Sleep Window (Hours),225
MS Polarity,224
Age at  Consent,224
Alcohol consumption,224
Metabolite,224
Smoking condition,224
Sample #,222
Ratio,220
Fecal Calprotectin,220
Immunosuppresants,220
zygosity,220
steroids,220
Method,220
mesalamine,220
CBC_EOSINOPHIL_CNT01,220
Tissue Type,219
exposure,217
Patient,217
Tissue Weight,216
Age (BOD-OD),214
Clinical_Parameters,214
Age (now),214
Stage OB,214
NUM_MALES,213
BRAF_V600E,212
DLCO,212
Time (hours),212
PCS,210
Protein,210
Time_sampled,209
Age (months),209
Sea_level_anomaly,209
Particulate_carbon,209
Absolute_depth,209
MS Method,207
HTA,207
Drinks/day,207
Mn treatment (uM),207
INTERNAL_STANDARD,207
Treatment duration,206
COLLECTION_METHOD,206
Treatment group,206
SMOKING_PACK_YEARS01,206
Cell Line,206
Wght_birth,205
COVID_Status,204
protein ug/vial,204
nmr_batch,203
Samples time,200
Study date,200
Acute renal failure,200
Pre vs. Post,200
Group Number,200
MECFS,200
Visit Number,200
PRETERM BIRTH,200
ANIMAL_ANIMAL_SUPPLIER,199
Tissue Weight (mg),198
Muscle type,198
surgery,198
ferm,197
strains,197
Skeletal Muscle Treatment,197
Compartment,197
time_stab,197
State,196
Average length(cm),196
collection_info,196
No of samples for width,196
country_of_origin,196
Average width(cm),196
Genotyping sample id,196
Date variety,196
No of samples for weight,196
Data set,196
Average weight,196
Collection information,196
No of samples for length,196
Biosample availability,196
Country of origin,196
Picture file,196
SD width(cm),196
date_variety,196
SD length(cm),196
SPECIES_GROUP,195
COLUMN_PRESSURE,195
Anaphylaxis,194
Study Phenotype,193
GeneXpert MTB/RIF Ct values,193
Health State,192
pool aliquot,192
mother.child,192
Yeast Matrix,192
Specimen_Freezer,191
Specimen_Container_Hierarchy,191
Specimen_Container_Position,191
Specimen_Container_Name,191
Specimen_Freeze.Thaw_Cycles,191
Specimen_Received_Date,191
Specimen_CHEAR_Additional_Fields_Lab_Hub,191
Specimen_CHEAR_Additional_Fields_Analyses,191
Specimen_Comments,191
Specimen_Type,191
Specimen_Class,191
Specimen_Created_On,191
Specimen_CHEAR_Additional_Fields_PID,191
Incubation,191
Specimen_CHEAR_Additional_Fields_Study_ID,191
concentration,191
cell number,191
MGIT (days),191
Grade,190
Nodule Classification,190
Cancer Type,190
Emphysema/COPD,190
Preeclampsia,189
Developmental Timepoint,189
SAMPLE_SPIKING,188
SAMPLE_RESUSPENSION,187
GenoType,186
Diurnal_Cycle,186
Sample source information,186
Sample.condition,186
HBI,185
CHEAR Sample name,185
Notes.Global,184
Analytical platform,184
Donor,183
S_Gender,182
Tracer,181
Ht_in,180
Analyzed target,180
Extracted Sample,180
Irradiation,180
Wt_lbs,180
10001 Visit 2 Colon NA#2,180
Factor_Dilutionseries,180
Biological material,180
ph treatment,180
DO treatment,180
F,180
Former,180
WaistCirc_in,180
Row,178
BMI_cat,178
Column,178
Sub-group,177
ANIMAL_FEED,177
diagnosis,177
Diet_phase,176
Ding120_MX591366_posCSH_900483-009-001,175
Ding133_MX591555_negHILIC_900483-009-001,175
Maternal Treatment (injection),175
Cell Line Injected,175
Liver Lobe,175
ION_SOURCE_TEMPERATURE,175
210427bmgsa32_1,175
Ding120_MX591366_negCSH_900483-009-001,175
QRSAvg46,174
QRSavglast3,174
GA_sac,174
cutofftime,174
Disease State,174
Technique,174
fetus,174
Cortisol treatment,174
DCA treatment,174
breed,174
cortdate,174
oxytocin,174
oxytocintime,174
sac,174
MAPavglast3h,174
HRavglast3h,174
Specimen_Container_Row,173
Specimen_Container_Column,173
U13C Glucose Labelling Timepoint,173
GA_delivery,172
GA_sampling,172
ALKP,171
USER_SEX,171
RACE_WHITE,171
ACQUISITION_DATE,170
Severity of Disease,170
Sample Code,169
TCDD treatment(ug/kg),169
Study Group,168
TBIL,168
Soduim level,166
S-S PyC2-Gly (uM),166
brand_name,166
TREATMENT_COMPOUND,165
age at blood draw,165
BMI z-score,165
NCE,164
ESI mode,164
Tumor Width,164
Nuclear Grade,164
SubTypes,164
Metastatic,164
Age at Blood Draw,164
Drought,163
Nitrogen,163
Matrix,163
Number of pixels in region of interest,162
Organ*,162
Position of tissue section on MALDI scan slide (from left to right),162
Species*,162
Intervention,162
GA_surg,162
Brain Region,162
5XFAD Genotype,162
PROCESSING_METHOD,161
Life stage,161
CoA standard addition,160
Deposition,160
ER,160
Tissues,160
NUM_FEMALES,159
Plasma_Type,159
SCAN_RANGE_MOVERZ,159
collection time (zietgeber time (H:MM:SS),158
BMI [kg/m²],158
Blood Draw,158
Sample name,157
MASS_ACCURACY,157
DRY_GAS_FLOW,157
Tumor Present,156
Source_Name[gating],156
Chronic kidney disease,154
Sample_Data:RAW_FILE_NAME,154
Infection,154
METS,153
date,153
Date of Study,153
RAW_FILE_NAME(raw file name),152
group ID,152
COLLECTION_LOCATION,152
Race/Ethnicity,151
EGA_sampling,150
DRY_GAS_TEMP,150
WEIGHT_OR_WEIGHT_RANGE,150
Gender (F/M),150
Was SCCAI completed?,150
Bacterial sp,150
tissue mg/vial,150
rbc(cells/uL),150
ecotype,150
Short sample name,149
Period,149
DOL,149
RANDOMIZATION_ORDER,148
Bowel frequency during the day,148
Urgency of defecation,148
Bowel frequency during the night,148
Blood in the stool,148
CAPILLARY_TEMPERATURE,148
General well being over the past 24 hours,148
Set,147
PR,147
90 day mortality,147
spleen_weight,146
liver_weight,146
endpoint.dpi,146
SOURCE_TEMPERATURE,146
Stress Level (past week),145
delta_weight,145
StrenuousExercise(per week),145
Moderate Exercise(per week),145
Mild Exercise(per week),145
Dyspnoea,144
ANIMAL_HOUSING,144
Biological replicate identifier,144
TREATMENT_PROTOCOL_FILENAME,144
Targeted metabolites,144
Data file,144
Sampletreatment,143
COLLISION_GAS,142
Year of Sample Collection,141
Time(weeks),141
ANIMAL_LIGHT_CYCLE,141
Depth_m,141
Time_Point,141
collection_timepoint,140
organism_part,140
Transplantation group,140
Unit,140
Response,140
Cells_per_mL,140
Day of Expt,140
Acquisition mode,140
COUNT,140
Study Phase,140
IONIZATION,139
age (years),138
height (cm),138
weight  (kg),138
HER-2 neu,137
mouse,136
STORAGE_VIALS,136
ACQUISITION_PARAMETERS_FILE,136
Lyme EIA/ELISA Method,135
Lyme EIA/ELISA Result,135
Lyme IgM,135
Lyme IgG,135
PTLDS,135
Days post inoculation,135
Time_point,134
Ionization mode,134
60 day mortality,133
Time (h),133
Germfree versus conventional,132
NMR_experiment,132
Prog/Relapse by 9/7/11,131
100nM_Folic_Acid_Growth,131
% Emphysema,131
FEV1 percent predicted,131
NMR experiment,131
FEV1/FVC,131
Vol,130
Code,130
FOB (µL),130
Time-point,130
Station and Cast,130
Depth (m),130
Emphysema_Percent,129
FEV1_Percent_Predicted,129
COLLECTION_VIALS,129
RNA,129
FEV1_FVC,129
array,129
Diet of subject mice,129
Feeding period (wk),129
PHZ dose (mg),129
ANIMAL_WATER,128
Number of liquid or very soft stools in the past 24 hours:,128
SCANNING_RANGE,128
Death due to COVID-19?,127
GCMS Batch,127
GCMS Data Name,127
LCMS Batch,127
Ovalbumin Immunization,126
Peanut Sensitization,126
Bedding type,126
Parasite Stage,126
tracer,126
Experimental group,126
Animal,126
(units),125
Mice Tumor SI#,125
Specimen Group,125
Patient ID,125
Age (weeks),125
TYPE,124
Tube,123
SmokingStatus,123
Diet at Week 2,122
Weight (g),122
Organism part,122
Collection_time,122
HSV-1,122
WEAK_WASH_SOLVENT_NAME,121
FRAGMENTATION_METHOD,121
Figures,120
Suplement,120
time pt,120
COLLISION_ENERGY,120
NMR_Sample_prep_ID,120
lc_ms_method,120
experiment_number,120
Submission date,120
Experiment identifier,120
Growth_type,120
(~8ul/mg),120
SBP>,120
comment,120
Study Date,120
Protocole,119
Vol_L,119
VOLUMEORAMOUNT_COLLECTED,118
Tumor.Type,118
TREATMENT_DOSE,118
Average seed length(cm),118
13C6 Citrate (mM),118
No of samples for seed length,118
Citrate (mM),118
LPS (Time),118
Run order,118
Milk_process,118
Milk_group,118
Moment,117
COLLECTION_FREQUENCY,117
Smoke_Cig_Current,117
Disease_subclass,117
ethnicity,117
Previus_COVID,116
TIME,116
DESOLVATION_GAS_FLOW,115
SCANNING_CYCLE,115
Sample_id,115
Injury Severity,114
Blood Collection,114
Follow up,114
Toxicity,114
TRIGLYCERIDES (mg/dL),114
Age (years),114
Skin Biopsy,114
PCR (mg/dL),114
FERRITIN (ng/mL),114
Lactate dehydrogenase (U/L),114
CBC_BASOPHIL_CNT01,114
Therapy,114
AFTER_MEAL_TIME,114
SURGERY,114
timepoint (min),114
STRONG_WASH_SOLVENT_NAME,114
colonization,114
POST_SURGERY_TIME,114
Ion mode,113
source,113
SCCAI,113
SD seed length(cm),112
Incubated with  SIHUMI consortia,112
Taurine (20 mM),112
Sampling,112
CPAP,112
PCOS,112
Sulfonates after dilution (ng/mL),112
Sulfoquinovose (4 mM),112
OSA,112
Incubation_time,112
Incubated with Bilophila wadsworthia,112
SAMPLE_LOOP_SIZE,112
Time before death (weeks),112
Raw Data Folder and Date of Analysis,112
Months on dialysis,112
Sulfonate after Dilution (ng/mL),112
Urine creatinine (mmol/L),112
spleen_load,111
PEPI Score,111
Lab Ki67 Group,111
Histology,111
liver_load,111
Arm,111
Treatment*,111
Day after birth,111
Litter,111
Hour,111
Material,110
Challenge,110
diluted factor,110
Trigger,110
CAD,110
Eye,110
Collection locale,110
LCMSNeg Data Name,109
SKIMMER_VOLTAGE,109
MS2 CE,108
Metal Exposure,108
Combined Total Glycolytic Activity (COM TGAI) from PET-CT,108
Hb,108
Cultivar,108
Silicon treatment [g],108
matrix,108
lipid,108
Amount of sample,107
ION_SPRAY_VOLTAGE,106
biological replicate,106
modality,106
OD600,106
RBC,106
Date to bud break,106
Date of collection,106
OMSPA region,106
Sample_Group,105
technical replicate,105
LCMSPos Data Name,105
Gsk Exposure Time (h),105
sample  quantity),105
HDM_stimulated,105
name,105
Virulence,105
htnrx2,105
characteristics: genotype,104
organism,104
characteristics: exposure,104
Loading order,104
characteristics: strain,104
characteristics: age,104
ion mode,104
Age (d),104
characteristics,104
characteristics: tissue,104
METHODS_ID,103
Sample group,103
DESOLVATION_TEMPERATURE,103
Intestinal Segment,103
Cell_type,102
Age(years),102
Factor 1,102
Height(cm),102
Vaginal Bleeding,102
Group type,102
Weight(kg),102
OVEN_TEMPERATURE,101
CASE_CONTROL,101
Day post-crush,101
Years_Education,101
White wine type and source,101
Treatment time,101
How long smoked?,101
Tamoxyfen,100
HIV status,100
Year,100
Sample time,100
Taxane,100
data table name,100
Progressors,100
Mouse_strain,100
PISA (mm2),100
debridement,100
Adiposity,100
sample_vol_filtered_L,100
Sampling_Date,100
DATAFORMAT,100
Helath phenotype,100
Lung Cancer Stage,100
Tissue Location,100
Protcole,100
CELL_STRAIN_DETAILS,100
WLZ,99
label,99
UTC,99
Gestational age,98
Maternal age,98
initial pH,97
RESOLUTION_SETTING,97
Replica,97
EXPERIMENT,96
population replicate,96
Strain name,96
PlateNum,96
mass(mg),96
hardiness,96
BadSampOD,96
IsCtrl,96
Sampling day,96
Normalized final OD600,96
position,96
<enter factor name>,96
Cobalt concentration,96
Milk powder,96
plate_nr,96
height(cm),95
Algal strain or abiotic control condition,95
sample replicate IDs,94
Days Post Exposure,94
MS mode,94
SubCondition,94
BRONCH_DIAGNOSED01,94
Treatment Dosage,93
Gene type,93
Sample_Source,93
PROJECT_COMMENTS,93
PROCESSING_PARAMETERS_FILE,93
Cognitive Status,93
MDM2 Amplification,92
Time of run,92
Mouse #,92
GoldStage,92
heat_group,92
Treatment_Status,92
drug_group,92
SAMPLEPREP_PROTOCOL_ID,92
Organism type,92
Amount for LC-MS,92
Sample Preparation,92
assay,92
Factor2,92
TREATMENT_ROUTE,92
30 day mortality,91
Smoking_status,91
Sample_Class,91
Time_Kept_on_Ice_before_Frozen,90
Country_of_Origin,90
Treatment Response,90
Sample Identifer Instrument Run Name (POS),90
fraction,90
TREATMENT_VEHICLE,90
Industrialization_Category,90
group_mouse,90
WOMENWAIST,90
protein (ug/ul),90
Food type,90
tube label,90
Type of tumor,90
Pre or Post and food,90
atherosclerosis,90
Subject number,90
Result Code,90
Cancer,90
DISEASE_STATE,89
Experimental Factors,89
Gold Stage,89
Disease Group,89
status,89
MotherDietPegnecy_ FISH,88
MotherDietPegnecy_ FISHPROD,88
MotherDietPegnecy_ SHELLFIS,88
MotherDietPegnecy_ FATOTH,88
MotherDietPegnecy_ APPLE,88
ArgGroup,88
MotherDietPegnecy_ FATVEG,88
Next column contains,88
PFOS2_mother,88
MotherDietPegnecy_ BERRY,88
PFOS1_mother,88
MotherDietPegnecy_ NUTSEED,88
Child_ 6mo_length_cm,88
Child_ sex,88
Child_ 6mo_weight_kg,88
Child_ Fecal_calprotectin_9_months,88
Child_ Fecal_beta2_defensin_9_months,88
Child_ Fecal_calprotectin_6_months,88
Child_ Fecal_beta2_defensin_6_months,88
Child_ Fecal_calprotectin_3_months,88
Child_ Fecal_Beta2_defensin_3_months,88
Child_ 12mo_weight_kg,88
Child_ 12mo_length_cm,88
MotherDietPegnecy_ SDRINK,88
Child_ 9mo_weight_kg,88
MotherDietPegnecy_ FBDRINK,88
MotherDietPegnecy_ COFFEE,88
Child_ 9mo_length_cm,88
CONTROL_DIABETIC,88
MotherDietPegnecy_ FATLVEG,88
MotherDietPegnecy_ WHEAT,88
MotherDietPegnecy_ RYE,88
MotherDietPegnecy_ OATBAR,88
MotherDietPegnecy_ CEROTH,88
MotherDietPegnecy_ VEGCANN,88
MotherDietPegnecy_ FRUITCAN,88
Child_ 3mo_weight_kg,88
Child_ 3mo_length_cm,88
MotherDietPegnecy_ OIL,88
MotherDietPegnecy_ FATHARD,88
Child_ birth_length_cm,88
Experiment name,88
Child_ birth_weight_g,88
PFOA_mother,88
MotherDietPegnecy_ CITRUS,88
MotherDietPegnecy_ CABBAGE,88
MotherDietPegnecy_ PORK,88
MotherDietPegnecy_ CREAM,88
MotherDietPegnecy_ ROOT,88
MotherDietPegnecy_ ICECREAM,88
MotherDietPegnecy_ PEABEAN,88
MotherDietPegnecy_ TEA,88
FRAGMENT_VOLTAGE,88
NEBULIZER,88
MotherDietPegnecy_ SWEET,88
MotherDietPegnecy_ CHOCOLAT,88
MotherDietPegnecy_ SUGARSYR,88
Progressor,88
MotherDietPegnecy_ STARCH,88
MotherDietPegnecy_ SAUSAGE,88
MotherDietPegnecy_ MILK,88
MotherDietPegnecy_ MEATPROD,88
MotherDietPegnecy_ FRUITOTH,88
MotherDietPegnecy_ MILKOTH,88
MotherDietPegnecy_ SMILK,88
MotherDietPegnecy_ LAMM,88
MotherDietPegnecy_ BUTTMIX,88
MotherDietPegnecy_ CHEESE,88
MotherDietPegnecy_ FLAVSAUC,88
MotherDietPegnecy_ BEEF,88
MotherDietPegnecy_ POULTRY,88
MotherDietPegnecy_ POTATO,88
MotherDietPegnecy_ INGRMIS,88
MotherDietPegnecy_ POTAPROD,88
MotherDietPegnecy_ PASTA,88
MotherDietPegnecy_ MUSHRO,88
MotherDietPegnecy_ SOYAPROD,88
MotherDietPegnecy_ JUICE,88
MotherDietPegnecy_ EGG,88
time (mins),88
PFNA_mother,88
PFDA_mother,88
MotherDietPegnecy_ VEGFRU,88
PFHxS_mother,88
MotherDietPegnecy_ SALT,88
MotherDietPegnecy_ VEGONI,88
MotherDietPegnecy_ VEGLEAF,88
MotherDietPegnecy_ RICE,88
Compactin,87
KLA,87
Treatment Factor,87
statinrx2,87
Cell,87
Additive 1,87
NO status,87
"Child_ Fecal beta2 defensin, 12 months",87
Child_ Fecal_calprotectin_12_months,87
Additive 2,87
Time (hr),87
Environment,87
category,87
Family ID,86
Time Point (h),86
Acronym explanation,86
Sample Identifier Instrument Run Name (NEG),86
Draw Number,86
WASHING_BUFFER,85
Data presented,85
acute groups,85
Cage #,84
p53,84
IBS,84
Dicer,84
Amhr2,84
Pten,84
Date Captured,83
Surgery,83
approx_weight,83
Weeks Difference,83
Generation,82
MS_Sample,82
Dose,82
AcetateConc,82
tissue_mg,82
Annuli,82
Phenotypic grouping and treaments,82
well,82
TREATMENT_DOSEDURATION,82
TQ sample type,82
od600,82
Histology Liver,82
TG (CM),82
cleanup,82
LENGTH (CM),82
WEIGHT (KG),82
Construct,82
BMI Category,81
Duration of ART (from first ART to ATI) (years),81
RAW_FILE_NAME(Subject),81
Age at start of analytical treatment interuption (ATI) in years,81
Race/ethnicity,81
Pre-ATI CD4 cells/mm3,81
Source ACTG study,81
Followed for how many days after tretament interuption,81
Non controllers (NC=1) or post-treatment controller (PTC=2),81
Culture Type,81
RAW_FILE_NAME(Raw File Name ),81
Drug Treatment,81
Immune checkpoint inhibitor,81
Polar_MS_solvent_volume (uL),80
FVB Strain Mus musculus,80
Extraction method,80
Health Status,80
TARGET_SAMPLE_TEMPERATURE,80
Days to &gt;50 Copies,80
Medical History,80
Phase,80
Vehicle (PBS) Control Treatment,80
Cells_in_polar_MS_analysis,80
PCV,80
PCV Color,80
Lipid Class,80
Diet modification,80
Polar_NMR_solvent_volume (uL),80
IONISATION,80
Radiation Duration,80
Calving date,80
Cellular_toxicity (fmol),80
Cells_in_polar_NMR_analysis,80
Diet Assignment,80
TOTAL PROTEIN (g/100mL),80
Meets waist cutoffs for MetSyn,79
Meets HDL cutoffs for MetSyn,79
Meets triglyceride cutoffs for MetSyn,79
Meets glucose cutoffs for MetSyn,79
Metabolic syndrome,79
ERI,79
Meets blood pressure cutoffs for MetSyn,79
Study Arm,78
PZC (&lt; 660 ug/L),78
RAW_FILE_NAME(Pos raw file name),78
RAW_FILE_NAME(Neg raw file name),78
Factors,78
Solvent,78
Experimental variables,78
culture_tempurature,78
culture_time (h),78
13C_label,78
culture_conditions,78
Subject type,78
Group label,78
years_of_illness,78
disease_state,78
ACE/ARB Inhibitor,77
control/diabetic,77
eNOS background,77
Sample.weight.[mg],77
region,77
Culture Medium,77
ExperimentDescription,77
TMEM SNP,76
RETENTION_TIME,76
ALB,76
AJCC_stage,76
FMT,76
DEXAMETHOSONE on,76
VERY Quick prog/ slow prog,75
Percent D2O,75
Carbon source,75
MS ionization mode,75
Treamtent group,75
Days to &gt;1000 Copies,75
Sample source inrormation,75
CA199,75
OCTPOLE_VOLTAGE,74
IONIZATION_ENERGY,74
MS level,74
EPO,74
Amount,73
Inocula,73
COLLECTION_PROTOCOL_ID,73
CEA,73
Storage condition,72
B6 Supplementation,72
Strain source,72
Folder Name,72
B6 Status,72
Pellet size,72
Combined label,72
RACE_WHT_BLK_OTH,72
10001 Visit 2 Stool NA#7,72
Day Collected,72
PfCRT Haplotype,72
RAW_FILE_NAME(Raw file name for oxPC),72
RAW_FILE_NAME(Raw file name for oxPE),72
RACE_WHT_OTH,72
RAW_FILE_NAME(raw_data_file for PC),72
RAW_FILE_NAME(raw_data_file for PE),72
groupID,72
Histology Swim Bladder,72
Colonized,72
Samplet_Type,72
Stretch Cycle,72
Culture Time,72
Collection Day,72
Histology Adipose,71
COD.OWL,71
Symotons,71
Taxon,71
pheotype,71
Extracted Volume (µL),71
Standard Dilution Factor,71
Culture #,71
Sample day,71
Glucose conc,71
brain region,71
Factor1***,70
CA153,69
CELL_BIOSOURCE_OR_SUPPLIER,69
Treatment Time,69
blood draw_age,68
CBT_Responder,68
Race_Ethnicity,68
plate_media_tare,68
Isotopic Tracer,68
Case-Control,68
Tumor_staging_before_chemo,68
"Treatment (1=control, 2=treatment)",68
RAW_FILE_NAME(Raw file name for Ox-PE),67
SAMPLE_DERIVATIZATION,67
Lung,67
CA125,67
m/z of reporter ion,66
classification_based on growth rate,66
Sample origin,66
Variety,66
Benzene_Exposure_Category,66
WEAK_WASH_VOLUME,66
classification_based on risks,66
GA_cort,66
Sample replicate,66
TIME_PROGRAM,65
COLLECTION_TUBE_TEMP,65
GROUP_ID,65
cell_line,65
NECROPSY NOTES:,65
SAMPLEPREP_PROTOCOL_COMMENTS,65
Differentiation stage,64
Tissue Region,64
2018_Mass_Spec ID,64
2018_Run_position,64
CELL_MEDIA,64
Genetic cluster,64
Soil pH,64
Developmental Stage,64
Treament,64
CRC Diagnosis,64
Abdominal pain location (symptom),64
clinical diagnosis,64
Pool #,64
Constitution,64
Sampling time,64
Concentration (ug/ml),64
receptive_anal_sex_frequency,63
Days to two consecutive &gt;1000 Copies,63
antibiotics_past_6_months,63
Extraction from condensate,63
timing of metabolite extract addition,63
Broad taxon,63
cd4_value,63
BMI (kg/m2),63
weight (kg),63
soil type,63
MSM,63
vaccine,63
antibiotic_1,63
HIV,63
Season,63
Botanical Family,63
Biovolume filtered_uL,63
Plant Species,63
CardiacDisease,63
high_risk,63
TRANSFERLINE_TEMPERATURE,63
developmental stage,63
arv_NRTI,63
arv_PE,63
dilution factor,63
arv_PI,63
Short ID,63
nmol C filtered,63
arv_NNRTI,63
arv_II,63
arv_AEI,63
SAMPLE_SYRINGE_SIZE,62
Infection Status,62
Treatment1,62
CHROMATOGRAPHY_COMMENTS,62
2020_Mass_Spec_ID,62
Visit #,62
TimeGroup,62
SampleSource,62
2020_Run_position,62
LV/RV,62
protein levels (mg/ml),61
mx sample,61
mx class,61
volume (ul),61
caries status,61
Run number,61
Data file type,61
Tissue Factor,61
Tissue factor,61
Treatment factor,61
RAW_FILE_NAME(Sample Number),60
pH_Treatment,60
TreatmentDuration (days),60
ODMAmetabotye,60
Growth phase,60
REAGENT_GAS,60
Time_point(days),60
DO Treatment,60
BMI group,60
pH Treatment,60
RACE_Black,60
Smoke Status,60
Tissue_TIME,60
treatment_type,60
treatment_time,60
Treatment Duration (days),60
GI tract location,60
Volume(uL),60
Raw file name,60
Xoo infection,60
sample source,60
Amount of Material (g),60
Number_of_cells_extracted,60
DO_Treatment,60
WCMC Number,60
MS_solvent_volume (uL),60
NMR_solvent_volume (uL),60
REP,59
RAW_FILE_NAME(Raw file name for PE),59
drc_rank,59
methylation_rank,59
Pack Years,59
smk_hx,59
age_cat,59
RAW_FILE_NAME(Raw file name for PC),59
lipitor,59
bmi_cat,59
BAT_SUV_mean,59
RAW_FILE_NAME(Raw file name for PI),59
BAT_Volume,59
FILE,59
IDH expression,59
Concentration of MgSO4(w/v),58
dry_weight,58
dry_weight%units,58
sub treatment,58
Ovalbumin sensitisation,58
RAW_FILE_NAME(File ID pos),58
RAW_FILE_NAME(File ID neg),58
CURRENT_SMOKER_V1,58
VET SCORE (Adipose),58
Duration,57
Spike,57
Reproductive Status,57
BLOOD_SERUM_OR_PLASMA,57
SPRAY_VOLTAGE,57
Treadmill Speed,57
Capture Location,57
TREATMENT_PROTOCOL_ID,57
Glucose,56
As Exposure,56
DIZE,56
Mino,56
Reactor,56
Ang II,56
lineage_5,56
Treatment Duration,56
MCT,56
growth_phase,56
Day post infection,56
UCP-3 Polymorphism,56
daily_dose,55
Days post-infection,55
diplotype,55
fev1_pct,55
ever_smoked,55
pc20,55
viral_load_value,55
Analyte,55
EXTRACT_CLEANUP,55
SUBJECT_COMMENTS,55
Rat ID,55
HUMAN_RACE,55
Wnt3a treatment,54
Time (s),54
Injury severity,54
Batches,54
Retina Attachment,54
Saline treatment,54
Time (min),54
Germination,54
Fasted vs Fed,54
HUMAN_INCLUSION_CRITERIA,54
Collection Timepoint,54
Crush,54
MH,54
Subject Identifer Instrument Run Name (POS),54
CELL LINE,54
Labelint time (hours),54
protein prep,54
ion_mode,54
Subject Identifier Instrument Run Name (NEG),53
Injection Number,53
Feeding,53
TREATMENT_DOSEVOLUME,53
Histopathological_Status,52
Mixture,52
Pulmonary TB status,52
ADDITIVES,52
Genotype/Treatment,52
Hyperoxia exposure,52
BASELINE_ASTHMA_DX,52
Antiviral_Treatment,52
HIV_status,52
RV infection,52
plate_media_tare%units,52
glucose>,51
Gestational age (weeks),51
Mouse_Genotype,51
Postnatal age (weeks),51
File Name,50
Cold Ischemia (Hrs),50
PHS Increased Risk Donor,50
DCD DONOR,50
Cold Ischemia (min),50
DONOR WEIGHT (kg),50
Expeimental factors,50
A1C Category,50
DONOR HEIGHT (cm),50
ionizationMode,50
AGE (years),50
Hepatits B Core Ab +,50
ABO,50
Hep C Positive Donor,50
DONOR CAUSE OF DEATH,50
Positive Raw Data File Names,50
RECOVERY DATE,50
OPO,50
strain/country,50
Experimental variable,50
timept,50
REMDESIVIR on,50
HUMAN_EXCLUSION_CRITERIA,49
ANIMAL_ENDP_EUTHANASIA,49
RAW_FILE_NAME(File),49
PRECURSOR_TYPE,49
Acute Kidney Injury,49
SampleOrder,48
POS/NEG,48
RAW_FILE_NAME(raw data file names),48
TG>,48
ZT_time,48
Urine_volume,48
Vol. water added  for homogenization (uL),48
mass (mg),48
PairID,48
pos_or_neg,48
Side,48
ExperRep,48
Biological_Replicate,48
Treat,48
BioRep,48
Experimentalgroup,48
Labelling,48
Time activated with peptide,48
COD.EXT,48
Nanomaterial,48
Exposure time,48
Initial Vol (uL),48
day post-anthesis,48
Run_Day,48
Rawfilename,48
COLLECTION_DURATION,48
Subject_species,48
Data,48
time course,48
dmrx2,48
Blood Draw Date,48
Sample class,47
AMY1 Group,47
Days after pollination,47
Time point (day),47
NMR sample ID,47
Treatment (8hrs),47
Analysis order,47
Positive days,47
Treatment conc.,47
siRNA,47
Techncial Replicates,47
Age at start of study,47
Experimental Condition,47
NMR pH,47
MS method,47
Chemo_response_numeric,46
Training,46
Preservation method,46
TREATMENT_PROTOCOL_COMMENTS,46
HUMAN_ETHNICITY,46
Cell lines,46
Donors,46
Time points,46
polar_split_ratio,45
CA242,45
injection_volume%units,45
EXTRACT_ENRICHMENT,45
factor description,45
Activity,45
MENWAIST,45
COLLECTION_PROTOCOL_COMMENTS,45
Total_Exacerbations,45
injection_volume,45
reconstitution_volume,45
COLLECTION_TIME,45
Growth Phase,45
reconstitution_volume%units,45
Treatment Condition,45
Sensitization,44
cell_count,44
Triglycerides,44
LDL,44
Leptin,44
CD4_percent,44
Factor1 Cell Line,44
CD8_HLADR_CD38_percent,44
CD8_count,44
Insulin,44
HDL,44
Adiponectin,44
CD8_percent,44
Lipodystrophy,44
Lymphocyte_count,44
DRCC ID,44
Start Diet,44
Lymphocyte_percent,44
Final Diet,44
CD8_CD38_single_positive_cells,44
CD4_HLADR_CD38_percent,44
CD4_count,44
Genotype_irradiation,44
Post-irradiation,44
CD4_CD38_single_positive_cells,44
sample_n,44
13C media incubation time,44
Diet intervention,44
Number of cells,44
Sorting,44
Sample Collection,44
Adjuvant,44
MCV,44
morphology,44
patient type,44
patientID,44
Immunization #,44
Age_Days,44
wing pads,44
lineage_6,44
SKOV3ip1 passage,43
TCPOBOP (mg/kg),43
Treated,43
Experiment day,43
Replica number,43
Age at start of study (years),43
In hosp mortality?,43
Baseline SOFA,43
Baseline APACHE II,43
Microorganism 1,43
Group Name,43
merged,43
QTL,43
Control diagnosis,43
Paediatric Group,43
Maternal_diet,43
Protein Amount (BCA),43
INTERNAL STANDARDS,43
Extraction_Approach,42
ANIMAL_FASTING,42
Vol_mL,42
Running Capacity,42
PEX_TOT0101,42
AMY1 group,42
Mouse DEXA fat %,42
Donor DEXA fat %,42
Growth media,42
Feeeding,42
SAMPLE_AMOUNT,42
ACSS2 inhibitor (Y/N),42
CELL_GROWTH_CONTAINER,42
Hours_of_label,42
day_of_experiment_DD_MM_YY,42
RNA_seq_available,42
Plant genotype,42
Mouse model,42
EXTRACTION BUFFER,42
maternal_diet,42
diet_condition,42
VOL_EXTRACTED,42
age_at_collection(years),42
weight(kg),42
colour_of_serum,42
Tracer_used,42
OFFSPRING_DIET,42
Nematode inoculation,42
MOTHER_DIET,42
[13C2-acetate] in mM,42
endo-borneol concentration,42
Attachment,42
Group name,42
Rat #,42
Area_heart,41
STRONG_WASH_VOLUME,41
Diet_notes,41
CELL_COUNTS,41
Ear Mark,41
Exacerbation Frequency,41
ANIMAL_ANESTHESIA,41
Mouse,41
Temp_degC,41
NAFLD.Status,41
16s_sample,40
Glycemic status,40
biological_sex,40
birth_year,40
Allergic infant,40
mg tissue,40
Sensitivity,40
RAW_FILE_NAME(Named Raw File_Heart Lipidomics),40
VTE,40
Initial volume (serum),40
Weight (cm),40
Length (cm),40
Nonpolar_NMR_solvent_volume (uL),40
Cells_in_nonpolar_MS_analysis,40
Nonpolar_MS_solvent_volume (uL),40
NMR pH (serum),40
Animal Group,40
A1C,40
White,40
DM Type,40
BPA_exposure,40
RAW_FILE_NAME(Named Raw File),40
Cells_in_nonpolar_NMR_analysis,40
MS ion mode,40
18-55 years,40
Male,40
control,40
Time (mins) (mins),40
BDR,40
Cold Susceptibility,40
Pre,40
NA,40
age(years),40
mature,40
spawned,40
hormone treatment,40
MTX (mg/week),40
COLLECTION_COUNTRY,40
Extraction Method Used,40
No.,40
Cause of Death,40
Topical medication/Other medications,40
Cause of death,40
Medications,40
Culture_stage,40
Doxorubicin dosage(μM),40
ETHNICITY_ASSIGNED,40
SUBJECT_FASTING,40
SUBJECT_SMOKER,40
SUBJECT_ILLNESS,40
Nutritional status,39
TGF,39
PFOR level,39
CD8_HLADR_single_positive_cells,39
FCS,39
REFED,39
sample,39
Genus_Or_Species,39
CD4_HLADR_single_positive_cells,39
MECFS_STATUS,38
Replicate_ID,38
Cells,38
AMY1group,38
Pregnancy status,38
bacterial_genotype,38
host_compartment,38
ID #,38
Tissue/Serum,37
ANIMAL_INCLUSION_CRITERIA,37
cell type,36
ANIMAL_ENDP_TISSUE_COLL_LIST,36
technical_rep,36
biologial_rep,36
sample_site,36
O2,36
Heart Area,36
Glucose labelling,36
Timepoint (weeks),36
Light Intensity (µmole photons m-2 s-1 ),36
Types,36
Labeling,36
tissue weight (mg),36
Age in days,36
Experimental factors,36
HX_HTN,36
RAW_FILE_NAME(Raw file name for oxPI),36
inj vol,36
Harvest_technique,36
10001 Visit 2 Serum,36
Storage_time,36
RAW_FILE_NAME Neg,36
drug treatment,36
CI_group,35
HEIGHT_OR_HEIGHT_RANGE,35
HUMAN_SMOKING_STATUS,35
Malaria Infection Status,35
plate_with_media_weight,34
sample_split_ratio,34
Surgery Type,34
plate_with_media_weight%units,34
cell line,34
Tissue Weight (g),33
BMI kg/m2,33
Age Category,33
Sex of individual,33
Growth condition,33
Study Site,33
Type of MS,33
Postconceptional age (weeks),33
Postmortem interval (hours),33
Time of exposure,33
Microbiome Status,33
Pair,33
Treatment response,33
Growth Temperature,33
Plasma Volume,32
processed_filename,32
Mutants,32
Type 1 reaction (T1R),32
KW,32
Diet (Normal or High Fat),32
Ring,32
Time Point (days),32
SamplePrepTreatment,32
Date analyzed,32
cd4_nadir,32
Dosage,32
Wild Type,32
Time (day),32
Glutamine label,32
Glucose label,32
Sample matrix,32
Sample_Data:Sample type,32
bleomycin/IPF,32
saline/HLF,32
Mice type,32
BMT Type,32
Number of Embryos,32
wt B6,32
Metabolites,32
Total Protein Abundance (ug),32
clinical form of leprosy,32
KD#2,31
Specify race,31
Instrument Run Name (POS),31
KD#1,31
mouse strain,31
Extraction blank,31
Datapoint,31
Time Restriction,31
diurnal cycle,31
Exposure Level,30
replicates,30
Replication,30
Parp1 KO,30
Parp1 WT (129S Background),30
Saline,30
Bleomycin,30
TIME_DAYS,30
study date,30
Diabetic or Healthy,30
Fasted or Fed,30
Temp/Duration,30
Date Collected in field,30
Raw File name,30
labeling status,30
CELL_PRIMARY_IMMORTALIZED,30
Instrument Run Name (NEG),30
Sample Amount mg,30
dose_group,30
test_article_name,30
CELL_ENVIR_COND,30
HX_Chol,30
microbial community type,30
location,30
Harvest Day,30
raw_data_time_format,30
Experimental Group,30
MX Class,29
File ID,29
CELL_PASSAGE_NUMBER,29
Notes,29
Cast,29
MX Sample,29
Sample_desc,29
Cell Line ID,29
Experiment Length,29
Gel,29
RAW_FILE_NAME(Raw file name for Ox-PC),29
steroid_status,29
BPA_DOSE,28
BVMT Learning T,28
Biocrates AbsoluteIDQ p180 KIT3 (FIA- POS) filename,28
BVMT Delay T,28
BVMT % Retained,28
Subject group,28
MaternalDiet,28
Biocrates AbsoluteIDQ p180 KIT2 (LCMS) filename,28
parasite_line,28
Fish Oil,28
Medication,28
age_years,28
CELL_STORAGE,28
CRE,28
Biocrates AbsoluteIDQ p180 KIT3 (FIA- NEG) filename,28
Pre-ATI CD4 count (cells/mm3),28
Weight_kg,28
wet_weight,28
wet_weight%units,28
Age_months,28
Time to viral rebound (days),28
Pre-ATI viral load (copies/ml),28
SamplingTimePoint,28
Pre-ATI CD4%,28
TreatmentDuration,28
Post-ATI viral setpoint (copies/ml),28
TreatmentGroup,28
Gender of Pup in Placenta,28
Days,28
metabolite_source,27
RAW_FILE_NAME( raw data file names),27
protein,27
Estrus Stage,27
HDLWOMEN<50,27
Factor_1 (tissue_type),27
SPLASH™ LIPIDOMIX® Quantitative Mass Spec Internal Standard dilution,27
Sample injection volume (µL),27
days post exposure to radiation,27
radiation source,27
HELIUM_FLOW,27
RAW_FILE_NAME(Raw file name for Ox-PI),27
RAW_FILE_NAME(File Name),26
"Time, hrs",26
TISSUE_CELL_QUANTITY_TAKEN,26
Tumor Site,26
Tumor Repository,26
DP Status,26
Day post-vaccination,26
Outcome,26
Tissue Classification (via Physician),26
Sample.Composition,26
Hormone treatment,26
DP Detection Method,26
CB_VISIT1,26
DOB,25
RAW_FILE_NAME(RAW_FILE_NAME(Raw file name (HILIC))),25
Mice strain,25
RAW_FILE_NAME(RAW_FILE_NAME(Raw file name (AMIDE))),25
ORGAN,25
Classification,25
Antibody Group,25
Virus treatment,24
Diseased,24
Treatment_compound,24
Sample_description,24
Arabidopsis Genotype,24
Collection Time (h),24
Precipitation,24
Stimulated,24
Harvest,24
Sample Collection (in Days),24
Sample_Data,24
CO2 Concentration (ppm),24
transfected,24
Main factor (1 to 5),24
Oxygen Condition,24
Chronic_Bronchitis,24
HUMAN_MEDICATIONS,24
Ring No,24
Cytarabin Treatment (uM),24
Concentration (uM),24
Plant Wounding Treatment,24
Cellular fraction,24
age(months),24
Tracers used,24
KO Type,24
Fasting Status,24
Collection_Time,24
partner,24
Cell Count,24
Bacteria presence,24
Experimental Factor 2 - Replicate,24
Experimental Factor 2 - Media,24
Genotype_Media supplement,24
Factor_1 (temperature),24
Experimental Factor 1 - Vector,24
sample ID,24
pre-infection sample,24
NTM pulmonary disease,24
M. abscessus,24
Factor_2 (bacteria presence),24
SH-SY5Y cell line,24
Analysed data,24
DFMO treatment (mM),24
Size (S/M/L),24
Transduced with,24
IDH1-R132H EXPRESSION,24
IDH1-R132H INHIBITOR,24
body weight,24
Right Hippocampus,23
Fasnall Concentration,23
RAW_FILE_NAME(mzXML File Names (Negative Scans)),23
Drug_spiked_in,23
Subject_type,23
AUTOMATIC_GAIN_CONTROL,23
Type of glucose,23
Age group,23
RAW_FILE_NAME(rawdata name),23
RAW_FILE_NAME(mzXML File Names (Positive Scans)),23
JWN ID,22
Isotopically labeled,22
observation,22
Chemoresistance Status,22
Duplicate Pair,22
CELL_TYPE,22
Ripening stage,22
VISIT,22
GENOTYPE,22
RAW_FILE_NAME(Raw data_NEG),22
lung_disease,22
CHROMATOGRAPHY,22
CELL_HARVESTING,22
conditions,22
Control,22
JWN_ID,22
File name (Endocannabinoid data),22
File name (Ceramide data),22
Left Hippocampus,22
.raw data file,22
sample name(backup),21
CAS,21
Fat Muscle,21
Light,21
Compound,21
StartVolume,21
Genotype of fly lines,21
Genotype Shorthand,21
Histology Type Conformed - CAP,21
PLANT_LIGHT_PERIOD,21
Cobalamin,21
Vol_intracellular_µL,21
Sample Description,21
Vol_filtered_mL,21
Tcell_proliferation_01_CD8,20
Tcell_proliferation_02_CD4,20
Tcell_proliferation_02_CD8,20
Adipose tissue,20
IDO_Activity,20
Human Stool,20
genetic status,20
Serologic finding (+ or - for PGL-I),20
Chemical Treatment,20
INTERFACE_VOLTAGE,20
Day of Liver Harvest Post-Birth,20
Functional_Composite_Score,20
Initial_Population_Doubling_Level,20
RFU,20
PLANT_TEMP,20
Trial Number,20
Hours of Exposure,20
Total_Cells_Seeded,20
Final_Cell_Yield,20
PLANT_GROWTH_LOCATION,20
Gentotype,20
Day of Serum Harvest Post-Birth,20
Final_Population_Doubling_Level,20
HUMAN_FASTING,20
Raw File Name:,20
Tcell_proliferation_01_CD4,20
Candida,19
subject type,19
Immunotherapy,19
group2,19
Sample Label,19
labeltype,19
CELL_PCT_CONFLUENCE,19
ANIMAL_VET_TREATMENTS,19
radiation dose,19
Media type,19
IDH1_MUTATION_STATUS,18
preservation method,18
shATRX plasmid,18
Specimen_Container_Row.D  Specimen_Container_Column,18
RAW_FILE_NAME(Raw file),18
Culture_condition,18
LPS (ng/mL),18
IDH1-R132H mutation,18
Live Birth,18
Seminal quality,18
buffer C_Ell,18
Depot location,18
co-factor added to lysate,18
13C label,18
Acclimatization temperature,18
PMI (hours),18
"1,2-13C2-labeled glucose concentration, g/L",18
"Labeling time, min",18
Heat exposure,18
Plant_organs,18
experimental factor,18
TISSUE_CELL_IDENTIFICATION,18
Type of media samples,18
Device,18
Platform Type,18
Biological repeat,18
CEFOPERAZONE,18
Mouse Cell Line,18
QC,17
Month,17
Genoytpe,17
Culture conditions,17
Dosage (Gy),17
"Disease? (0, no; 1, yes)",17
SUBCELLULAR_LOCATION,17
ACTIVATION_PARAMETER,17
ACTIVATION_TIME,17
CELL_MEDIA_LASTCHANGED,17
Tracer_Abbreviated,17
colonized bacteria,17
Progression,17
Gln Treatment,17
RhoA knockdown,16
Time (incubation),16
Time (days),16
Lactobacillus,16
Duration (weeks),16
Metabolome,16
Heat shock,16
pellet_weight%units,16
pellet_weight,16
Lipid Type,16
Stress,16
RhoC overexpression,16
Genoptye,16
DEN,16
RhoC knockdown,16
Analyses,16
Concentration (mg/mL),16
<Sex>,16
Sample detail,16
13C Label,16
RhoC drug,16
Normal,16
Immunizing agent,16
Folic_Acid_Concentration,16
Diapause,16
Technical Replicate (Region of Tumor),16
Protein_BCA,16
Prenatal Smoking,16
PLANT_GROWTH_STAGE,16
AOM,16
stress,16
Stimulation,16
Cell Count (in millions),15
Ectopic Gene Expression,15
Fungal species,15
RAW_FILE_NAME(Raw data file),15
hibernation,15
Bacterial Exposure,15
Dox Concentration,15
EXERCISE,15
Surgical condition,15
Days after ovulation,15
RAW_FILE_NAME(raw_data),15
Comments,15
lineage,15
TUBE_LENS_VOLTAGE,15
Transplant type,15
Method of analysis,15
Mice health condition,15
diabetes,15
Extraction,15
time of day,15
O.D.mL,15
HUMAN_TRIAL_TYPE,14
Embryo Type,14
Inoculum,14
RETENTION_INDEX,14
muscle Bmal1,14
Hours after start of re-feeding,14
iButOH concentration,14
Input material,14
Severe_Exacerbations,14
RAW_FILE_NAME(Raw File),14
model,14
Nudt7 Genotype,14
Priming,14
PLANT_METAB_QUENCH_METHOD,14
Agonist,14
Taking antibiotics,14
PLANT_HUMIDITY,14
Data Source,14
Rinse,14
Taking probiotics,14
*Factor,13
CELL_GROWTH_CONFIG,13
[13C2] Acetate,13
Spectra,13
ColonicTumors,13
SAMPLING_CONE,13
Grown in presence of NaCl (mM),13
PLANT_PLOT_DESIGN,13
ANTIBIOTICS,13
YOGURT,13
ALCOHOL,13
PfKelch13 mutation,13
disease,13
Artemisinin resistant,13
SHORT TERM RED MEAT,13
Protocol,12
Suspension,12
Biological_replicate,12
pH,12
malignant transformation,12
subtypes,12
GI_site,12
level of dysplasia,12
protein_extract dry weight (g),12
polar weight (g),12
reconstitution_volume (ul),12
expected_reconstitution_volume (ul),12
Tumor,12
NMR_probe,12
cell wet weight(g),12
Factor-1,12
Bafilomycin,12
PLANT_WATERING_REGIME,12
DESCRIPTION,12
Factor-2,12
Sample_descritpion,12
Burn Status,12
Zink,12
Infected,12
INFECTION TIME (0-24 Hrs),12
Rest/Exercise,12
Transplantation,12
Treatment_Time(min),12
Biovolume_extracted,12
Sample Collection Site,12
MEHP concentration,12
Sample groups,12
Experiment_name,12
Milk fraction,12
Alternative_identifications_in_the_study,12
Optic Density(OD),12
Cocaine concentration (ppb),12
D-tagatose (%),12
age(weeks),12
day after surgery,12
time_point%units,12
drug admin,12
RUNNING_VOLTAGE,12
Compounds,12
Acquisition_setting_identification_number,12
Relative Age,12
Plasmid,12
Elevation,12
Reverse Primer,12
Forward Primer,12
GAS_PRESSURE,11
Cocaine conentration (ppb),11
SCANNING,11
ANIMAL_ACCLIMATION_DURATION,11
PLANT_STORAGE,11
L-serine (mg/kg/day),11
PRECONDITIONING,11
Genoptype,11
time point (weeks),11
SOLVENT_C,11
LONG TERM RED MEAT INTAKE,11
Infused,11
Recurrence or Progression?,10
Node,10
Ionisation_mode,10
Metastasis,10
Caco2,10
subject ID,10
Mouse Type,10
STZ injection,10
ANIMAL_ENDP_CLINICAL_SIGNS,10
Mixture Concentration (mM),10
sample_id,10
Knockdown of IDH1,10
Tumour,10
Gene,10
13C-label position in pyruvate,10
HUMAN_ALCOHOL_DRUG_USE,10
Alox12/15 Status,10
Cellulose(%),10
Body Comp,10
Dysplasia,10
Used for MS/MS fragmentation,10
Input_metabolites,10
Metabolomics Sample ID,10
Biogenic Amines Sample ID Identifier,10
Lipidomics Sample ID,10
Case_Control,10
Weight (mg),10
Drug combination,10
IDH1 Knockdown,10
Growth Conditions,9
Psoriasis Status,9
PLANT_HARVEST_METHOD,9
HDLMEN<40,9
PLANT_NUTRITIONAL_REGIME,9
Time after hypoxia (days),9
Disease status,9
FeEDDHA (µM),9
Time Harvested,9
HUMAN_NUTRITION,9
Sample Status,9
Transfection,9
collected month,9
lipid extraction wet_weight,8
IONIZATION_POTENTIAL,8
cell quench wet_weight%units,8
cell quench wet_weight,8
HUMAN_PRESCRIPTION_OTC,8
1x PBS,8
Bacillary index,8
Iteration number,8
lipid extraction wet_weight%units,8
BP (mmHg),8
Rat,8
Incubation Temperature,8
IDH1_MUTATION,8
experimental factor(s),8
INTERNAL_STANDARD_MT,8
CELL_GROWTH_RATE,8
IFNgamma ng/mL),8
line,8
PLANT_HARVEST_DATE,8
IDh1 mutation,8
Instrument run modes,8
SHEATH_LIQUID,8
Duration (min),8
PLANT_GROWTH_SUPPORT,7
Days post-STZ,7
Spike-in (µL),7
Buffer (µL),7
Urine (µL),7
HUMAN_ENDP_CLINICAL_SIGNS,7
Timepoint of Collection,7
PLANT_ESTAB_DATE,7
HUMAN_LIFESTYLE_FACTORS,7
CELL_INOC_PROC,7
Treatment (Maternal Injection),7
CDL_TEMPERATURE,6
Bacterial Species / Inoculum,6
protocol.BCA_protein(mg),6
Cells(×106cells),6
Prediction Model (Coculture vs Axenic),6
cells wet_weight(g),6
polar extract wet_weight(g),6
Lipopolysaccharide Treatment,6
dry_weight(g),6
Light treatment,6
Biological Replicate Number,6
Exposure to H2O2,6
Fractionation,6
Transgene,6
Expression vector,6
Variable,6
LPS (ug/mL),6
RUNNING_BUFFER,6
Specimen Species,6
CENPF,6
Additional Adjustments,6
Pancreas tissue type,6
RAW_FILE_NAME(Raw file name (Analyst file name)),6
Cell population,6
subject_type,5
Exctraction,5
SAMPLE_DRIPPING,5
rinsing_solution,5
bleomycin,5
ORGAN_SPECIFICATION,5
Analysis Type,5
CFU,5
Resuspension,5
Genetic background,5
ATOM_GUN_CURRENT,5
POLAR,4
CLIENT_MATRIX,4
BOX_NUMBER,4
NPC source,4
POS LATE,4
CLIENT_IDENTIFIER,4
SAMPLE_DESCRIPTION,4
POS EARLY,4
CLIENT_SAMPLE_ID,4
Extraction Method,4
GROUP_NAME,4
FG-4592(mg/kg),4
RAW_FILE_NAME(sample_name),4
DAYS,4
Sample Treatment,4
# cells,4
C. jejuni Infection,4
Genetic makeup,4
Extraction Time (hours),4
MIGRATION_TIME,4
PROBE_TIP,4
extraction type,4
SAMPLE_AMOUNT_UNITS,4
NEG,4
FG-4592(10 mg/kg),4
Prostate Cell Line,4
Protocols,4
HX_Dm,3
MATRIX,3
concs (mM),3
#  spots/spectra,3
Max metabolites in 1 spot,3
,3
tamoxifen(µM）,3
%13C,3
# of metabolites,3
ANALYSIS_COMMENTS,2
Duplicate Pair.D  Analysis Order,2
Standard,2
HCD (NCE units),2
INSTRUMENT_PARAMETERS_FILE,2
Collection Date (MM/DD/YYYY),2
NUM_FACTORS,1
ACQUISITION_TIME,1
ACQUISITION_ID,1
Pooled sample,1
LASER,1
ANALYSIS_DISPLAY,1
NUM_METABOLITES,1
